C07K 16/2854
Against selectins
Official title: {against selectins, e.g. CD62}
C07K16/2854 (Against selectins) appears on 137 US grants and 171 published applications in this corpus.
Search patents in C07K- Granted patents
- 137
- Published applications
- 171
- Assignees
- 100
- Inventors
- 379
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 3 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 1 | 0 |
| 1997 | 7 | 0 |
| 1998 | 17 | 0 |
| 1999 | 8 | 0 |
| 2000 | 8 | 0 |
| 2001 | 15 | 1 |
| 2002 | 4 | 10 |
| 2003 | 4 | 12 |
| 2004 | 3 | 9 |
| 2005 | 3 | 10 |
| 2006 | 1 | 4 |
| 2007 | 2 | 1 |
| 2008 | 0 | 6 |
| 2009 | 3 | 6 |
| 2010 | 3 | 6 |
| 2011 | 4 | 9 |
| 2012 | 2 | 7 |
| 2013 | 6 | 6 |
| 2014 | 3 | 7 |
| 2015 | 3 | 2 |
| 2016 | 4 | 3 |
| 2017 | 2 | 4 |
| 2018 | 1 | 6 |
| 2019 | 2 | 6 |
| 2020 | 3 | 8 |
| 2021 | 3 | 11 |
| 2022 | 3 | 13 |
| 2023 | 2 | 5 |
| 2024 | 5 | 8 |
| 2025 | 2 | 4 |
| 2026 | 1 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Anti-E-selectin antibodies, compositions and methods of use17 Mar 2026US 12,577,308 B2Pfizer Inc.
- Method for the reduction of host cell proteins in affinity chromatography23 Dec 2025US 12,503,487 B2Genentech, Inc.
- Epitope tags recognized by specific binders22 Jul 2025US 12,365,705 B2NANOTAG BIOTECHNOLOGIES GmbH
- Anti-peripheral lymph node addressin antibodies and uses thereof31 Dec 2024US 12,180,286 B2The Brigham and Women S Hospital, Inc.
- CD62L specific lentiviral vector particle for targeted transduction of T cell subsets25 Jun 2024US 12,018,273 B2Miltenyi Biorec B V. Co., KG
- Patrolling monocyte cellular therapy1 Oct 2026US 2026/0297525 A1New York Blood Center, Inc.
- Method for the reduction of host cell proteins in affinity chromatography10 Sep 2026US 2026/0265295 A1Genentech, Inc.
- Microenvironment actuated t-cells and uses thereof20 Aug 2026US 2026/0242732 A1
- 2-Arylbenzimidazole Compounds for the Treatment of Hemoglobinopathies16 Jul 2026US 2026/0199293 A1Tranquis Therapeutics, Inc.
- Epitope tags recognized by specific binders16 Apr 2026US 2026/0103489 A1NANOTAG BIOTECHNOLOGIES GmbH
Most cited
By later US patents
- Method of making transgenic mice lacking endogenous heavy chains1,057US 5,939,598 AAbgenix, Inc. · 1999
- Human antibodies derived from immunized xenomice1,057US 6,075,181 AAbgenix, Inc. · 2000
- Human antibodies derived from immunized xenomice943US 6,150,584 AAbgenix, Inc. · 2000
- Generation of xenogeneic antibodies639US 6,114,598 AAbgenix, Inc. · 2000
- Generation of Xenogenetic antibodies561US 6,162,963 AAbgenix, Inc. · 2000